Lymphadenopathy Clinical Trials

9 recruitingLast updated: May 11, 2026

There are 9 actively recruiting lymphadenopathy clinical trials across 7 countries. Studies span Not Applicable. Top locations include Beijing, Beijing Municipality, China, Ho Chi Minh City, Ho Chi Minh, Vietnam, Huizhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Lymphadenopathy Trials at a Glance

9 actively recruiting trials for lymphadenopathy are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Beijing, Ho Chi Minh City, and Huizhou. Lead sponsors running lymphadenopathy studies include George Washington University, Humanitas Hospital, Italy, and China-Japan Friendship Hospital.

Browse lymphadenopathy trials by phase

Treatments under study

About Lymphadenopathy Clinical Trials

Looking for clinical trials for Lymphadenopathy? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymphadenopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymphadenopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Comparison of Two Needle Agitation Strategies in Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) for Diagnostic Yield

Mediastinal Lymphadenopathy
Phan Quang Hieu180 enrolled1 locationNCT07424807
Recruiting
Not Applicable

Safety and Performance Profile of Cryobiopsy in Bronchial Endoscopy

Mediastinal LymphadenopathyMediastinal LesionsDiffuse Interstitial Lung Diseases
University Hospital, Strasbourg, France30 enrolled1 locationNCT07301697
Recruiting
Not Applicable

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

Lymphadenopathy RetroperitonealStage II Testicular Seminoma
University Health Network, Toronto25 enrolled1 locationNCT05345158
Recruiting
Not Applicable

Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy

Mediastinal LymphadenopathySarcoidosis, PulmonaryMediastinal Diseases
George Washington University55 enrolled1 locationNCT05374447
Recruiting

Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes

LymphomaLymphnode MetastasisLymphadenopathy+1 more
Peking University Third Hospital779 enrolled1 locationNCT07155954
Recruiting

Mediastinal EBUS Cryobiopsy Study In Sweden

Lung CancerLymphomaSarcoidosis+2 more
Region Skane200 enrolled2 locationsNCT06347939
Recruiting
Not Applicable

EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE

Lymphadenopathy
Shanghai Chest Hospital162 enrolled3 locationsNCT06913569
Recruiting
Not Applicable

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Pancreas CancerPancreas AdenocarcinomaPancreaticoduodenal Lymphadenopathy
Humanitas Hospital, Italy180 enrolled1 locationNCT04571294
Recruiting
Not Applicable

The Comparison of EBUS-TBNA, TBMC Via a Tunnel, and TBFB Via a Tunnel in Diagnosing Mediastinal Lymphadenopathy.

Lymphadenopathy HilarLymphadenopathy Mediastinal
China-Japan Friendship Hospital552 enrolled1 locationNCT06262620